Abstract
The present invention provides new coumestans compounds and processes for the preparation of coumestans, pharmaceutical compositions having a coumestan as an active pharmaceutical ingredient, and methods of utilizing coumestans as selective estrogen receptor modulators (SERMs) for treating estrogen dependent diseases such as breast cancer.
Original language | American English |
---|---|
Patent number | WO2014106848 |
IPC | C07D 493/ 04 A I |
Priority date | 7/01/13 |
State | Published - 10 Jul 2014 |